Filgrastim Active Not Recruiting Phase N/A Trials for Stage IV Adult Diffuse Large Cell Lymphoma / Intraocular Lymphoma / Stage III Grade 2 Follicular Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Adult Diffuse Large Cell Lymphoma / Stage III Adult Diffuse Large Cell Lymphoma / Stage I Multiple Myeloma / Contiguous Stage II Marginal Zone Lymphoma / Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue / Stage I Grade 2 Follicular Lymphoma / Stage IV Adult Diffuse Small Cleaved Cell Lymphoma / Stage III Adult Burkitt Lymphoma / Recurrent Grade 2 Follicular Lymphoma / Stage IV Marginal Zone Lymphoma / Recurrent Adult Diffuse Mixed Cell Lymphoma / Stage IV Grade 1 Follicular Lymphoma / Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma / Refractory Multiple Myeloma / Stage I Adult Diffuse Large Cell Lymphoma / Recurrent Marginal Zone Lymphoma / Stage I Adult Burkitt Lymphoma / Progressive Hairy Cell Leukemia, Initial Treatment / Recurrent Adult Burkitt Lymphoma / Stage III Adult Lymphoblastic Lymphoma / Contiguous Stage II Grade 1 Follicular Lymphoma / Contiguous Stage II Grade 2 Follicular Lymphoma / Stage III Adult Diffuse Small Cleaved Cell Lymphoma / Small Intestine Lymphoma / Recurrent Grade 3 Follicular Lymphoma / Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma / Adult Grade III Lymphomatoid Granulomatosis / Stage I Mantle Cell Lymphoma / Stage IV Adult Diffuse Mixed Cell Lymphoma / Noncontiguous Stage II Marginal Zone Lymphoma / Stage III Grade 1 Follicular Lymphoma / Untreated Hairy Cell Leukemia / Nodal marginal zone B-cell lymphomas / Contiguous Stage II Adult Burkitt Lymphoma / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma / Stage III Multiple Myeloma / Stage III Adult Immunoblastic Large Cell Lymphoma / Noncontiguous Stage II Adult Lymphoblastic Lymphoma / Stage I Adult Immunoblastic Large Cell Lymphoma / Stage II Multiple Myeloma / Noncontiguous Stage II Grade 2 Follicular Lymphoma / Stage IV Adult Lymphoblastic Lymphoma / Recurrent Adult Immunoblastic Large Cell Lymphoma / Stage I Grade 1 Follicular Lymphoma / Contiguous Stage II Mantle Cell Lymphoma / Recurrent Adult Lymphoblastic Lymphoma / Recurrent Grade 1 Follicular Lymphoma / Stage III Mantle Cell Lymphoma / Splenic Marginal Zone Lymphoma / B-Cell Chronic Lymphocytic Leukemia / Noncontiguous Stage II Grade 3 Follicular Lymphoma / Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma / Stage I Adult Diffuse Small Cleaved Cell Lymphoma / Waldenström's Macroglobulinemia (WM) / Contiguous Stage II Adult Lymphoblastic Lymphoma / Contiguous Stage II Adult Diffuse Large Cell Lymphoma / Noncontiguous Stage II Mantle Cell Lymphoma / Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma / Stage III Grade 3 Follicular Lymphoma / Noncontiguous Stage II Small Lymphocytic Lymphoma / Stage I Grade 3 Follicular Lymphoma / Stage I Adult Lymphoblastic Lymphoma / Cutaneous B-Cell Non-Hodgkin Lymphoma / Refractory Hairy Cell Leukemia / Stage IV Grade 2 Follicular Lymphoma / Stage IV Adult Burkitt Lymphoma / Stage I Adult Diffuse Mixed Cell Lymphoma / Recurrent Small Lymphocytic Lymphoma / Noncontiguous Stage II Grade 1 Follicular Lymphoma / Contiguous Stage II Small Lymphocytic Lymphoma / Contiguous Stage II Grade 3 Follicular Lymphoma / Stage III Marginal Zone Lymphoma / Stage IV Adult Immunoblastic Large Cell Lymphoma / Recurrent Adult Grade III Lymphomatoid Granulomatosis / Stage IV Grade 3 Follicular Lymphoma / Noncontiguous Stage II Adult Burkitt Lymphoma / Stage I Small Lymphocytic Lymphoma / Stage III Adult Diffuse Mixed Cell Lymphoma / Stage IV Mantle Cell Lymphoma / Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma / Stage III Small Lymphocytic Lymphoma / Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma / Stage IV Small Lymphocytic Lymphoma / Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma / Stage I Marginal Zone Lymphoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02037256Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant